NS5A-IN-3 is a potent NS5A inhibitor used for the treatment of hepatitis C virus (HCV) infection, demonstrating high efficacy against HCV genotype 1b, enhanced activity against genotype 3a (GT3a), and a higher barrier to resistance compared to daclatasvir.